Skip to main content
. 2021 Feb 11;10:599604. doi: 10.3389/fonc.2020.599604

Figure 1.

Figure 1

(A) First-line palliative treatment options for HR+ ABC patients (N = 1,847). (B) Second-line palliative treatment HR+ABC patients (N = 1,424). ET, endocrine therapy; CT, chemotherapy; TT, target therapy.